Alistair Ring

Summary

Affiliation: Institute of Cancer Research
Country: UK

Publications

  1. ncbi 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research
    Alistair Ring
    Breast Unit, Department of Medicine, Royal Marsden Hospital, London, UK
    Breast Cancer Res 5:113-6. 2003
  2. ncbi 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research
    Julia E Head
    Section of Medicine, Institute of Cancer Research, Sutton, UK
    Breast Cancer Res 5:109-12. 2003
  3. ncbi Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells
    Lila Zabaglo
    Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom
    Cytometry A 55:102-8. 2003
  4. ncbi Circulating tumour cells in breast cancer
    Alistair Ring
    Academic Department of Biochemistry and the Breast Unit, Royal Marsden Hospital, London, UK
    Lancet Oncol 5:79-88. 2004
  5. ncbi Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications
    Alistair Ring
    Department of Academic Biochemistry, Wallace Wing, Royal Marsden Hospital, London, United Kingdom
    Clin Breast Cancer 4:S34-41. 2003
  6. ncbi Mechanisms of tamoxifen resistance
    Alistair Ring
    Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Rd, London. SW3 6JJ, UK
    Endocr Relat Cancer 11:643-58. 2004
  7. ncbi Breast cancer
    Alistair Ring
    Department of Medicine, Breast Unit, Royal Marsden Hospital, London, UK
    Cancer Chemother Biol Response Modif 22:545-61. 2005
  8. ncbi Breast cancer and pregnancy
    Alistair Ring
    Sussex Cancer Centre, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK
    Breast 16:S155-8. 2007

Detail Information

Publications8

  1. ncbi 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research
    Alistair Ring
    Breast Unit, Department of Medicine, Royal Marsden Hospital, London, UK
    Breast Cancer Res 5:113-6. 2003
    ..Summaries are also given of the clinical plenary lectures and minisymposia on adjuvant therapy and aromatase inhibitors...
  2. ncbi 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research
    Julia E Head
    Section of Medicine, Institute of Cancer Research, Sutton, UK
    Breast Cancer Res 5:109-12. 2003
    ..Presentations on genetic susceptibility and the development of prognostic and predictive markers also created much interest...
  3. ncbi Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells
    Lila Zabaglo
    Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom
    Cytometry A 55:102-8. 2003
    ..Additionally, biomarker analysis may allow a more rational approach to therapeutics. We have developed a new method for the detection and characterisation of these cells...
  4. ncbi Circulating tumour cells in breast cancer
    Alistair Ring
    Academic Department of Biochemistry and the Breast Unit, Royal Marsden Hospital, London, UK
    Lancet Oncol 5:79-88. 2004
    ..We also review the clinical studies in breast cancer and discuss the potential relevance of this research to the future management of the disorder...
  5. ncbi Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications
    Alistair Ring
    Department of Academic Biochemistry, Wallace Wing, Royal Marsden Hospital, London, United Kingdom
    Clin Breast Cancer 4:S34-41. 2003
    ..In contrast, early data from the neoadjuvant setting suggest that responses to aromatase inhibitors may be maintained in patients with HER2 overexpression...
  6. ncbi Mechanisms of tamoxifen resistance
    Alistair Ring
    Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Rd, London. SW3 6JJ, UK
    Endocr Relat Cancer 11:643-58. 2004
    ..The experimental and clinical evidence supporting these mechanisms of tamoxifen resistance are discussed in this review...
  7. ncbi Breast cancer
    Alistair Ring
    Department of Medicine, Breast Unit, Royal Marsden Hospital, London, UK
    Cancer Chemother Biol Response Modif 22:545-61. 2005
  8. ncbi Breast cancer and pregnancy
    Alistair Ring
    Sussex Cancer Centre, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK
    Breast 16:S155-8. 2007
    ..However, the principle concern with all of these interventions is what the long-term implications for the newborn might be...